Search Results
Dec 02, 2025, 04:00 ET Ziwig Endotest®: Scientific Validation Published in NEJM Evidence
saliva-based diagnosisThe Ziwig Endotest® was evaluated through the analysis of 109 salivary microRNAs, combining next-generation sequencing (NGS) with artificial intelligence. Diagnostic interpretations were performed blindly, without prior knowledge of the patients' clinical status, ensuring
More news about: Ziwig
Dec 02, 2025, 03:00 ET Ziwig Endotest®: Validación científica publicada en NEJM Evidence
basado en salivaEl Ziwig Endotest® se evaluó mediante el análisis de 109 microARN salivales, combinando secuenciación de nueva generación (NGS) con inteligencia artificial. Las interpretaciones diagnósticas se realizaron a ciegas, sin conocimiento previo del estado clínico de los pacientes,
More news about: Ziwig
Dec 01, 2025, 10:00 ET Pillar Biosciences Announces Final CMS Pricing Determination for oncoReveal® CDx
PiVAT® technologies, Pillar's localized testing model reduces diagnostic costs and increases access to complex NGS testing worldwide. The company currently offers more than 20 NGS testing kits in IVD and RUO formats, with additional panels in development. Pillar Biosciences is headquartered in Natick,
More news about: Pillar Biosciences, Inc.
Nov 27, 2025, 10:30 ET Pet DNA Testing Market to Reach $960.7 Million, Globally, by 2034 at 9.3% CAGR: Allied Market Research
driving the adoption of DNA testing kits and services.Rapid advancement in genetic testing technologies, including next-generation sequencing (NGS), which has improved the accuracy, affordability, and speed of pet DNA analysis is another factor driving the market growth. Leading providers such as
More news about: Allied Market Research
Nov 25, 2025, 10:01 ET Veterinary Reference Laboratory Market worth US$6.46 billion by 2030 with 6.3% CAGR | MarketsandMarkets™.
AI-driven data analysis, and expanding assay menus to enhance accuracy, efficiency, and turnaround time. The adoption of next-generation sequencing (NGS), PCR-based diagnostics, immunodiagnostics, and high-throughput analyzers has significantly improved disease detection capabilities across companion
More news about: MarketsandMarkets
Nov 25, 2025, 09:00 ET Lexogen Successfully Completes Large-Scale Human Primary Cell Next Gen Sequencing Project with Ochre Bio
discovery platform. Lexogen NGS Services has been a trusted long-term sequencing partner to Ochre Bio delivering high-quality RNA-Seq data from various sample inputs including bio-banked FFPE to micro-organ and primary hepatocyte samples at scale and in time. Lexogen NGS Services operates in accordance
More news about: LEXOGEN
Nov 25, 2025, 09:00 ET Lexogen Successfully Completes Large-Scale Human Primary Cell Next Gen Sequencing Project with Ochre Bio
discovery platform. Lexogen NGS Services has been a trusted long-term sequencing partner to Ochre Bio delivering high-quality RNA-Seq data from various sample inputs including bio-banked FFPE to micro-organ and primary hepatocyte samples at scale and in time. Lexogen NGS Services operates in accordance
More news about: LEXOGEN
Nov 25, 2025, 09:00 ET Lexogen schließt erfolgreich ein groß angelegtes Next-Gen-Sequenzierungsprojekt für menschliche Primärzellen mit Ochre Bio ab
Lexogen NGS Services ist seit langem ein zuverlässiger Sequenzierungspartner von Ochre Bio und liefert hochwertige RNA-Seq-Daten aus verschiedenen Proben, einschließlich FFPE-Proben aus Biobanken, Mikroorgan-Proben sowie primären Hepatozytenproben in großem Maßstab und fristgerecht. Lexogen NGS Services
More news about: LEXOGEN
Nov 25, 2025, 09:00 ET Lexogen completa con éxito un proyecto de secuenciación de células primarias humanas con Ochre Bio
humanos. Lexogen NGS Services ha sido un socio de confianza de Ochre Bio durante años, ofreciendo datos de ARN-Seq de alta calidad a partir de diversas muestras, incluyendo muestras de FFPE de biobancos, de microorganismos y de hepatocitos primarios, a escala y a tiempo. Lexogen NGS Services opera
More news about: LEXOGEN
Nov 25, 2025, 09:00 ET Lexogen achève avec succès un projet de séquençage nouvelle génération à grande échelle sur des cellules primaires humaines avec Ochre Bio
120 000 échantillons évalués avec la plateforme propriétaire de Lexogen de profilage d'expression génique à haute résolution sans extraction et les services NGS.
More news about: LEXOGEN
Nov 21, 2025, 16:39 ET Zymo Research Advances Wastewater Surveillance as Sponsor of the Microbes in Wastewater Symposium 2026
comprehensive range of technologies, including solutions for sample collection, DNA/RNA purification, NGS library preparation, microbiomics, transcriptomics, epigenomics, genomics, and Next-Generation Sequencing (NGS) services.Zymo Research, a private biotech company established in 1994 and headquartered
More news about: Zymo Research Corp.
Nov 21, 2025, 12:39 ET Hackensack Meridian John Theurer Cancer Center Unveils Research at the 67th American Society of Hematology Annual Meeting
body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL): Results from the EndRAD trial (PTCTC ONC1701) (ABSTRACT 25-12959) A phase 2 dose
More news about: Hackensack Meridian John Theurer Cancer Center
Nov 20, 2025, 13:05 ET Next Gen Additive Manufacturing Poised Market for Explosive Growth to $145 Billion by 2033 Driven by Smart Materials and AI Integration - Strategic Revenue Insights
https://www.strategicrevenueinsights.com/industry/clinical-oncology-next-generation-sequencing-ngs-market
More news about: Strategic Revenue Insights
Nov 20, 2025, 10:01 ET Genomics Market worth $85.09 billion by 2030 with 12.6% CAGR | MarketsandMarkets™
end of the period. Market growth can be attributed to increasing government funding for genomics projects, rising applications of NGS in chronic disorders, advancements in NGS platforms, and growing applications of genomics. Furthermore, the increasing use of genomics in precision medicine further contributes
More news about: MarketsandMarkets
Nov 18, 2025, 10:50 ET MiRNA Microarray Kits And Reagents Market Surges to USD 2.45 Billion by 2033, Propelled by 8.5% CAGR - Verified Market Reports®
reproducibility; (2) the requirement for extensive clinical validation to meet regulatory thresholds; and (3) competitive pressure from next-generation sequencing (NGS) and PCR-based platforms that are lowering costs and improving sensitivity. To Purchase a Comprehensive
More news about: Verified Market Reports
Nov 18, 2025, 09:00 ET Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights
Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal's certified provider network, Zymo Research's NGS Services division is now authorized to deliver services
More news about: Zymo Research Corp.
Nov 18, 2025, 09:00 ET Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights
Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal's certified provider network, Zymo Research's NGS Services division is now authorized to deliver services
More news about: Zymo Research Corp.
Nov 18, 2025, 09:00 ET Zymo Research gibt strategische Partnerschaft mit biomodal bekannt, um Multiom-Erkenntnisse der nächsten Generation zu liefern
Next-Generation-Sequencing (NGS), ist eine strategische Partnerschaft mit biomodal eingegangen, einem auf Omics-Technologie basierenden Unternehmen für Life-Science-Technologie und -Analytik. Als Teil des zertifizierten Anbieternetzwerks von biomodal ist die Abteilung NGS Services von Zymo Research nun
More news about: Zymo Research Corp.
Nov 18, 2025, 05:40 ET Oncology Molecular Diagnostics Market to Reach US$ 6.46 Billion by 2033, Driven by Precision Oncology, and Accelerating Biomarker-Based Therapies - According to DataM Intelligence
The oncology molecular diagnostics landscape is undergoing a profound shift-driven by next-generation sequencing (NGS), liquid biopsy adoption, FDA-approved companion diagnostics, multi-cancer early detection (MCED) innovation, and a strong pipeline of novel oncology
More news about: DataM Intelligence 4 Market Research LLP
Nov 14, 2025, 12:46 ET Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform
Callisto™ Sample Preparation Platform. The collaboration combines Volta's fully automated NGS sample preparation system with NEB's trusted, high-performance NEBNext NGS sample preparation kits to deliver reproducible, walk- away automation. "Our collaboration
More news about: Volta Labs Inc.
Nov 13, 2025, 10:15 ET Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
Sequencing NGS Data Analysis NGS Primary Data Analysis NGS Secondary Data Analysis NGS Tertiary Data Analysis
More news about: Grand View Research, Inc.
Nov 12, 2025, 14:00 ET Volta Labs Delivers the Ultimate Whole Genome Sequencing Sample Prep Launch: Callisto™ Now Unifies the Entire WGS Ecosystem on One Platform
BOSTON, Nov. 12, 2025 /PRNewswire/ -- Volta Labs, a leader in NGS automation, today announced a major expansion of its Callisto™ Sample Preparation Platform. Callisto now delivers fully automated DNA library preparation
More news about: Volta Labs Inc.
Nov 12, 2025, 10:01 ET Life Science Instrumentation Market worth $92.5 billion by 2031 with 6.5% CAGR | MarketsandMarkets™
expansion in manufacturing for pharma-biopharma companies, greater demand from applied industries, ongoing innovations in next-generation sequencing (NGS) technologies, and the rising prevalence of infectious diseases.
More news about: MarketsandMarkets
Nov 12, 2025, 10:00 ET Carolina Molecular Partners with Pixelgen, Becomes First US Certified Service Provider for Pixelgen Proxiome Kit
disease mechanisms, drug response, and biomarker discovery. The workflow generates sequencer-ready libraries that integrate seamlessly with standard NGS platforms. "Partnering with Pixelgen is a direct extension of what our clients are asking for: bolstering molecular insights with
More news about: Pixelgen Technologies
Nov 12, 2025, 09:30 ET Pillar Biosciences Enables Rapid, Localized Tumor Profiling of Lymphoid Malignancies with Launch of New Kitted NGS Panel
single-tube, fully automatable NGS workflow that can be performed by any NGS-equipped molecular laboratory. "We are excited to launch oncoReveal Lymphoid, specifically designed to meet the needs of local laboratories looking for rapid and efficient NGS-based testing solutions to help
More news about: Pillar Biosciences, Inc.